Spain· ES:1191393001
QUOFENIX 300 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
A medicinal product containing delafloxacino, registered in Spain by A. Menarini Industrie Farmaceutiche Riunite S.R.L..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- delafloxacino
- Manufacturer
- A. Menarini Industrie Farmaceutiche Riunite S.R.L.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Delafloxacino in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomQuofenix 300mg powder for concentrate for solution for infusion vialsA. Menarini Farmaceutica Internazionale SRL
- IcelandQuofenixA. Menarini Industrie Farmaceutiche Riunite Srl
- SwedenQuofenix 300 mg Pulver till koncentrat till infusionsvätska, lösningA Menarini Manufacturing Logistics and Services s.r.l.
- SwitzerlandQuofenix 300 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA. Menarini GmbH
- FranceQUOFENIX 300 mg, poudre pour solution à diluer pour perfusionMENARINI ITALIE
- NetherlandsQuofenix 300 mg, poeder voor concentraat voor oplossing voor infusieA. Menarini Industrie Farmaceutiche Riunite S.r.l.
- ItalyQUOFENIX*10 cpr 450 mgA.MENARINI IND.FARM.RIUN.Srl
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Quofenix
- Liechtenstein · Quofenix
- Norway · Quofenix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/47d43c61-f236-4028-a55a-781232f85115 GET /v1/drugs/47d43c61-f236-4028-a55a-781232f85115?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1624620938000}",
"nregistro": "1191393001",
"substance": "delafloxacino"
}See everything about delafloxacino.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.